Markel Group, Inc.

  • Market Cap: Mid Cap
  • Industry: Insurance
  • ISIN: US5705351048
USD
2,043.39
-13.53 (-0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Markel Group, Inc. stock-summary
stock-summary
Markel Group, Inc.
Insurance
Markel Corporation is a financial holding company serving a range of markets. The Company's principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc. (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace. The U.S. Insurance segment includes all direct business and facultative placements written by its insurance subsidiaries domiciled in the United States. The International Insurance segment includes all direct business and facultative placements written by its insurance subsidiaries domiciled outside of the United States, including its syndicate at Lloyd's of London (Lloyd's). The Reinsurance segment includes all treaty reinsurance written across the Company.
Company Coordinates stock-summary
Company Details
4521 Highwoods Pkwy , GLEN ALLEN VA : 23060-6148
stock-summary
Tel: 1 804 7470136
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 120 Schemes (29.72%)

Foreign Institutions

Held by 299 Foreign Institutions (17.36%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Steven Markel
Chairman of the Board
Mr. Thomas Gayner
Co-Chief Executive Officer, Director
Mr. Richard Whitt
Co-Chief Executive Officer, Director
Mr. Stewart Kasen
Lead Independent Director
Mr. Mark Besca
Director
Ms. A. Lynne Puckett
Director
Mr. K. Bruce Connell
Independent Director
Ms. Diane Leopold
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
677 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 24,409 Million (Mid Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

12.67%

stock-summary
Price to Book

1.41